We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for sabizabulin (Adjutor Healthcare Pty Ltd)
Active ingredients
sabizabulin
Sponsor
Date of review outcome
Lapse date
Type
Provisional determination
Indication
For treatment of SARS-CoV-2 infection in hospitalised patients with moderate to severe COVID-19 infection who are at high risk for Acute Respiratory Distress Syndrome (ARDS)
Therapeutic area
Infectious diseases